C1-inhibitor attenuates hyperacute rejection and inhibits complement, leukocyte and platelet activation in an ex vivo pig-to-human perfusion model
- 1 May 1999
- journal article
- Published by Elsevier in Immunopharmacology
- Vol. 42 (1-3) , 231-243
- https://doi.org/10.1016/s0162-3109(99)00008-9
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Immunoglobulin Prolongs Survival of Pig Kidneys Perfused Ex Vivo with Human BloodScandinavian Journal of Immunology, 1998
- A Neoepitope‐Based Enzyme Immunoassay for Quantification of C1‐Inhibitor in Complex with C1r and C1sScandinavian Journal of Immunology, 1997
- PROTECTION OF PORCINE ENDOTHELIAL CELLS FROM COMPLEMENT-MEDIATED CYTOTOXICITY BY THE HUMAN COMPLEMENT REGULATORS CD59, C1 INHIBITOR, AND SOLUBLE COMPLEMENT RECEPTOR TYPE 1Transplantation, 1996
- Significance of the Regulation of Plasma Kallikrein by α2MaAnnals of the New York Academy of Sciences, 1994
- Prevention Of Complement-Mediated Activation Of Xenogeneic Endothelial Cells In An In Vitro Model Of Xenograft Hyperacute Rejection By C1 InhibitorTransplantation, 1993
- The response of human platelets to activated components of the complement systemImmunology Today, 1991
- C1 Inhibitor and Hereditary Angioneurotic EdemaAnnual Review of Immunology, 1988
- Contact Factors in Health and DiseaseSeminars in Thrombosis and Hemostasis, 1987
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970